SPECTRUM PHARMACEUTICALS INC Accounts and Financing Receivable, after Allowance for Credit Loss
SPECTRUM PHARMACEUTICALS INC had Accounts and Financing Receivable, after Allowance for Credit Loss of $1.51 million as of 2017-09-30, per its 10-Q filed 2017-11-03.
Discontinued › Balance Sheet › Assets
us-gaap:AccountsAndNotesReceivableNet · last filed 2017-11-03
- 2017-09-30: Accounts and Financing Receivable, after Allowance for Credit Loss $1.51M.
- 2017-06-30: Accounts and Financing Receivable, after Allowance for Credit Loss $1.51M.
- 2017-03-31: Accounts and Financing Receivable, after Allowance for Credit Loss $1.51M.
- 2016-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss $0.00.
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss |
|---|---|
| 2017-09-30 | $1.51M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $1.51M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $1.51M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-03 |
| 2016-09-30 | $1.50M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.50M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.50M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-14 |